Matica Subsidiary Receives Sales Licence

Author's Avatar
Feb 24, 2020
Article's Main Image

TORONTO, ONTARIO / ACCESSWIRE / February 24, 2020 / Matica Enterprises Inc. (CSE:MMJ) (Frankfurt: 39N) (OTCQB:MMJFF) ("Matica" or the "Company") is pleased to announce that its subsidiary, RoyalMax Biotechnology Canada Inc. ("RoyalMax"), has received both the Standard Processing and Sale For Medical Purposes Licences from Health Canada. The standard processing licence will allow RoyalMax to deliver products to the recreational market throughout Canada. With the medical sales licence RoyalMax, will be able to provide product directly to appropriately documented patients who use cannabis for medical purposes.